Non-compliance with Good Manufacturing Practice was found at one of the manufacturers, resulting in suspension of the GMP certificate, so it cannot be excluded that keeping the product on the market may pose a risk to patient health. Potential effects: possible risk to patient health, including lack of treatment efficacy or unpredictable adverse effects.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batches 1464005K and 1462014C; patients should check the batch number and, if they possess these packs, return them to a pharmacy or consult a doctor or pharmacist to ensur...
The Chief Pharmaceutical Inspector withdrew batches 1464005K and 1462014C of Tadalafil Aristo from the market throughout Poland and granted the decision immediate enforceability, obliging the marketin...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related